4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-13-000172
CIK 0000899866operating
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:00 PM ET
Size
8.5 KB
Accession
0000899866-13-000172
Insider Transaction Report
Form 4
MADRI JOSEPH A
Director
Transactions
- Exercise/Conversion
Common Stock, par value $.0001 per share
2013-09-16$5.55/sh+30,000$166,500→ 209,217 total - Exercise/Conversion
Common Stock
2013-09-16$115.00/sh−30,000$3,450,000→ 0 totalExercise: $5.55From: 2005-03-10Exp: 2014-12-10→ Common Stock (30,000 underlying) - Sale
Common Stock, par value $.0001 per share
2013-09-16$115.00/sh−30,000$3,450,000→ 179,217 total
Footnotes (2)
- [F1]The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $115.00 - $115.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:00 PM ET
- Size
- 8.5 KB